Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Cash (2016 - 2025)

Historic Change in Cash for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to $27.8 million.

  • Tandem Diabetes Care's Change in Cash rose 197414.31% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year increase of 24035.06%. This contributed to the annual value of $10.4 million for FY2024, which is 10912.11% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Change in Cash is $27.8 million, which was up 197414.31% from $10.5 million recorded in Q2 2025.
  • Tandem Diabetes Care's 5-year Change in Cash high stood at $48.7 million for Q4 2022, and its period low was -$51.1 million during Q3 2023.
  • Over the past 5 years, Tandem Diabetes Care's median Change in Cash value was $3.0 million (recorded in 2023), while the average stood at -$140315.8.
  • The largest annual percentage gain for Tandem Diabetes Care's Change in Cash in the last 5 years was 197414.31% (2025), contrasted with its biggest fall of 1420810.81% (2025).
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Change in Cash stood at -$41.2 million in 2021, then skyrocketed by 218.3% to $48.7 million in 2022, then tumbled by 142.57% to -$20.7 million in 2023, then soared by 197.36% to $20.2 million in 2024, then soared by 37.83% to $27.8 million in 2025.
  • Its last three reported values are $27.8 million in Q3 2025, $10.5 million for Q2 2025, and -$15.7 million during Q1 2025.